Hogy Medical FY25 profit dips; restructuring drives future growth

Hogy Medical (TSE:3593) reported consolidated net sales of ¥39.138 billion for the fiscal year ending March 31, 2025, a slight increase of 0.1% YoY, according to Japanese GAAP. Operating profit decreased by 8.6% to ¥3.810 billion, and profit attributable to owners of the parent company fell by 45.8% to ¥1.520 billion, which included policy-driven write-downs. While sales of premium surgical kits grew, traditional kit products and non-woven materials saw declines.